Amendment to Option Agreement between BrainStorm Cell Therapeutics Inc. and David Stolick

Summary

This amendment updates the original Option Agreement between BrainStorm Cell Therapeutics Inc. and David Stolick, originally dated March 29, 2005. The amendment replaces Exhibit B, specifying that Mr. Stolick is granted 400,000 options at a purchase price of $0.15 per share, vesting in 36 equal monthly installments starting March 13, 2005, and expiring on February 13, 2015. All other terms of the original agreement remain unchanged.

EX-10.2 3 v034788_ex10-2.txt AMENDMENT TO OPTION AGREEMENT The Option Agreement, dated as of March 29, 2005, between Mr. David Stolick and BrainStorm Cell Therapeutics Inc. (the "Option Agreement") is hereby amended as follows (capitalized terms used herein and not defined herein shall have the respective meaning ascribed to such terms in the Option Agreement): 1. Exhibit B of the Option Agreement shall be deleted in its entirety and replaced with the following: "Exhibit B Terms of the Option Name of the Optionee: David Stolick Date of the Grant: 3.29.05 Designation: Capital Gain Option (CGO) 1. Number of Options granted: 400,000 2. Purchase Price: $0.15 3. Vesting Dates: 36 equal monthly installments beginning on March 13, 2005 4. Expiration Date: February 13, 2015 (unless otherwise adjusted as provided herein)" 2. Except as aforesaid, the Option Agreement shall remain in full force and effect. IN WITNESS WHEREOF, the undersigned have caused this Amendment to be executed on the 6th day of February, 2006. BRAINSTORM CELL THERAPEUTICS INC. By: /s/ Yoram Drucker -------------------------------- Name: Yoram Drucker Title: Chief Operating Officer OPTIONEE /s/ David Stolick -------------------------------- Name: David Stolick